Cure My Disease

Don't miss your cure!

 Log in / Sign up

Medical glue vs. internal bleeding: a new hope?

NCT ID NCT07753005

Not yet recruiting Disease control Sponsor: Aesculap AG Source: ClinicalTrials.gov ↗

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study is looking at how well a medical glue called Histoacryl stops bleeding from arteries in the chest or abdomen. It will follow adults in Japan who receive this treatment during routine care to see if it works and is safe. The main goal is to check if bleeding stops within a month without needing another procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Histoacryl (a medical glue used to block bleeding arteries)
What this could lead to
If successful, this could confirm Histoacryl as a reliable option to stop internal bleeding without surgery, potentially improving outcomes for patients with severe hemorrhage.
What could go wrong
This is an observational study, so it doesn't test against a comparison group. Results may vary in real-world settings, and there are risks like incomplete blockage or need for repeat procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gastrointestinal Hemorrhage Hemoptysis Hemorrhage Postpartum Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL HEMORRHAGE HEMOPTYSIS HEMORRHAGE POSTPARTUM HEMORRHAGE

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Aichi Cancer Center Hospital

    Nagoya, Aichi-ken, 464-8681, Japan

  • Fujita Health University Hospital

    Toyoake, Aichi-ken, 470-1192, Japan

  • Gifu University Hospital

    Gifu, Gifu, 501-1194, Japan

  • Hokkaido University Hospital

    Sapporo, Hokkaido, 060-8648, Japan

  • Hyogo Medical University Hospital

    Nishinomiya, Hyōgo, 663-8501, Japan

  • Nara Medical University Hospital

    Kashihara, Nara, 634-8522, Japan

  • National Cancer Center Hospital East

    Kashiwa, Chiba, 277-8577, Japan

  • National Cancer Center Hospital,

    Tokyo, Tokyo, 104-0045, Japan

  • Shizuoka Cancer Center

    Nagaizumi-chō, Shizuoka, 411-8777, Japan

  • St. Marianna University Hospital

    Kawasaki, Kawasaki, 216-8511, Japan

  • Teikyo University Hospital

    Tokyo, Tokyo, 173-8606, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.